Product Description e.p.t.q S 100 Li is a dermal filler based on stabilized and purified hyaluronic acid. Elastic "HIVE-structure" maintains an ideal viscoelasticity of this product. E.p.t.q. applies for a more precise cleaning process to eliminate residual BDDE. Various side effects that may occur after the procedure are minimized as e.p.t.q keeps endotoxin below 0.1 EU/ ml.
DESCRIPTION OF THE PRODUCT e.p.t.q. (epitique) means "exquisite" + "technique". e.p.t.q. will show you the exquisite technology to express the ideal beauty : Safe with Minimized MOD Level of 1% through low BDDE : High cohesiveness for excellent molding : Homogenous particle size for exquisite molding : Minimized endotoxin level and calficiation that may cause initial side effects TECHNICAL DETAILS For Face • S100 - for Superficial to Mid Dermis • S300 - for Mid to Deep Dermis • S500 - For Subcutaneous area
e.p.t.q S500 1 x 1 ml Facial augmentation
e.p.t.q S500 is a hyaluronic acid filler with the thickest consistency compared to the other fillers in the range. It is suitable for a more drastic facial augmentation. The properties of the filler ensure perfect sculpting of the areas such as cheekbones. e.p.t.q. is a word formed from 'Exquisite' and 'Technique'. e.p.t.q. was born for women who want to manage exquisite detail of beauty to achieve their true self. e.p.t.q. range consists of 3 fillers and is manufactured according to "The 9 Essentials" process in the South Korea. Company's R&D center has their own 9 criteria to produce high-safety quality HA fillers which is strictly controlled than European standards. The hyaluronic acid filler e.p.t.q. is produced according to the "The 9 Essentials" process promises an exquisite product that meets stringent safety standards.
Areas:
Nose
Lips
Chin
Cheekbones
Depth of injection: Subcutaneous/Supraperiostal areas
Benefits:
Safety of raw ingredients
High purity HA content for duration and prevention of swelling
High viscoelasticity
Homogeneous particle implementation technology
No detection of residual chemical catalyst substance through the complete crosslinking process
Aseptic manufacturing environment to prevent side effects
Less than 0.1 EU/ml of Endotoxin
Minimizes pain with the same pH and osmotic pressure as the human body